Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) was down 9% during mid-day trading on Monday . The stock traded as low as $1.20 and last traded at $1.32. Approximately 1,011 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 2,942 shares. The stock had previously closed at $1.45.
Relief Therapeutics Price Performance
The firm has a 50-day moving average of $1.66 and a 200-day moving average of $1.99.
About Relief Therapeutics
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Featured Stories
- Five stocks we like better than Relief Therapeutics
- How to invest in blue chip stocks
- United Airlines Soars on Earnings Beat
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- J.B. Hunt Hits the Skids: Lower Prices to Come
- How to Use Stock Screeners to Find Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
